ANI Pharmaceuticals | ANIP - SCHULD

Aktienkurs
78.36
Täglich Wechseln
-1.78 -2.22%
Monatlich
2.71%
Jährlich
15.03%
Q2 Prognose
76.22




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Assertio Holdings USD 38.87M 615K 2023-09
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 32.02B 615M 2025-09
Omeros USD 442.16M 199K 2023-09
Perrigo USD 3.64B 7.2M 2025-09
Sun Pharmaceuticals INR 23.62B 2.1B 2025-03
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09